Lee Danner & Bass Inc Ionis Pharmaceuticals Inc Transaction History
Lee Danner & Bass Inc
- $1.24 Billion
- Q4 2024
A detailed history of Lee Danner & Bass Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Lee Danner & Bass Inc holds 22 shares of IONS stock, worth $667. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22Holding current value
$667% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
411Shares Held
139MCall Options Held
957KPut Options Held
701K-
Vanguard Group Inc Valley Forge, PA16.5MShares$500 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$430 Million0.34% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$348 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$313 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$263 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.31B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...